Key result
Vaccination with attenuated poliomyelitis virus completely protected 18 monkeys against intracerebral viral challenge and was safely administered to two human subjects without systemic ill effects.
Why the study?
Does vaccination with attenuated poliomyelitis virus protect against infection in monkeys and is it safe in humans?
Does vaccination with attenuated poliomyelitis virus protect against infection in monkeys and is it safe in humans?
Early preclinical and human case evidence demonstrating the potential efficacy and safety of an attenuated poliomyelitis vaccine.
Answers are grounded in this paper and cite their sources.
Supports progression to human trials for attenuated poliomyelitis vaccine; leaves open demonstration of clinical efficacy and durability.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kolmer et al. (1935) studied Acute anterior poliomyelitis (n=20). Attenuated poliomyelitis virus vaccine in sodium ricinoleate vs. Unvaccinated controls was evaluated on Development of infection following intracerebral injection of infective virus. Vaccination with attenuated poliomyelitis virus completely protected 18 monkeys against intracerebral viral challenge and was safely administered to two human subjects without systemic ill effects.
Synapse has enriched 10 related papers. Consider them for comparative context: